Clover Health Investments (CLOV) Other Operating Expenses (2019 - 2026)

Clover Health Investments has reported Other Operating Expenses for 8 years, with the latest figure at $647.2 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses rose 56.74% year-over-year to $647.2 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 billion (up 52.82% YoY), and the FY2025 full-year result was $1.8 billion, up 44.76% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $647.2 million, up from $470.9 million in the prior quarter.
• The five-year high for Other Operating Expenses was $904.2 million in Q1 2022, with the low at -$1.5 billion in Q4 2022.
• Historically, Other Operating Expenses has averaged $361.5 million across 5 years, with a median of $344.0 million in 2023.
• The largest YoY upside for Other Operating Expenses was 222.0% in 2022 against a maximum downside of 367.91% in 2022.
• Clover Health Investments' Other Operating Expenses stood at -$1.5 billion in 2022, then surged by 122.04% to $332.8 million in 2023, then dropped by 8.02% to $306.1 million in 2024, then soared by 53.82% to $470.9 million in 2025, then surged by 37.45% to $647.2 million in 2026.
• The last three Other Operating Expenses figures came in at $647.2 million (Q1 2026), $470.9 million (Q4 2025), and $472.1 million (Q3 2025), per Business Quant data.